Form 4: Cyanotech CEO Increases Common Stock Holdings Through RSU Vesting

Cyanotech Corp's President and CEO, Matthew Keith Custer, acquired 2,075 shares of common stock through the vesting of restricted stock units, increasing his direct common stock holdings to 6,754 shares.

Summary

• Matthew Keith Custer, President and CEO, and Director of Cyanotech Corp, acquired 2,075 shares of common stock on July 29, 2025.
• This acquisition resulted from the vesting and conversion of restricted stock units (RSUs) under a Rule 10b5-1 plan.
• Following this transaction, Custer's direct beneficial ownership of common stock increased to 6,754 shares from a previous holding of 4,679 shares.
• He also directly beneficially owns 64,137 restricted stock units, which are scheduled to vest as follows: 34 shares on April 6, 2026; 21,368 shares on June 16, 2026; 21,368 shares on June 16, 2027; and 21,367 shares on June 16, 2028, contingent on his continued service.

Sentiment

Score: 7

Explanation: The transaction reflects a routine vesting of restricted stock units, leading to an increase in the CEO's direct common stock ownership, which is generally viewed positively as it aligns management's interests with shareholders.

Positives

• Increased direct ownership of common stock by the President and CEO, Matthew Keith Custer, from 4,679 shares to 6,754 shares, demonstrating continued alignment with shareholder interests.
• The vesting of restricted stock units indicates the fulfillment of long-term incentive compensation, potentially motivating management.
• The transaction was made pursuant to a Rule 10b5-1 plan, indicating a pre-arranged and systematic approach to equity compensation.

Negatives

• No direct negatives are apparent from this insider transaction report.

Risks

• Future vesting of 64,137 restricted stock units is contingent upon the reporting person's continued service with the company on the respective vesting dates.

Future Outlook

The company anticipates issuing additional common stock to Matthew Keith Custer on future vesting dates (April 6, 2026, June 16, 2026, June 16, 2027, and June 16, 2028), contingent on his continued service.

Management Comments

• No direct management comments or notable quotes are provided in this Form 4 filing.

Industry Context

This Form 4 filing details an insider transaction, which is a routine disclosure for publicly traded companies. It does not provide information directly related to broader industry trends or competitive landscape.

Comparison to Industry Standards

• This filing reports an individual insider transaction and does not contain information suitable for comparison to industry-wide financial or operational benchmarks.

Management Changes

Corporate Governance

Legal Proceedings

• No legal proceedings or regulatory matters are mentioned in this filing.

Related Party Transactions

• The reported transaction involves the vesting of restricted stock units, which is a standard component of executive compensation and not indicative of unusual related party dealings.

Stakeholder Impact

• Shareholders may view the increase in the CEO's direct common stock ownership positively, as it enhances alignment between management and shareholder interests.

Next Steps

• Future vesting of 64,137 restricted stock units for Matthew Keith Custer on April 6, 2026 (34 shares), June 16, 2026 (21,368 shares), June 16, 2027 (21,368 shares), and June 16, 2028 (21,367 shares), subject to continued service.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction involving the vesting of restricted stock units and conversion to common stock. While it shows increased insider ownership, which is generally positive, it does not provide sufficient new information or financial performance data to warrant a change in investment recommendation. Investors should consider this as a minor positive signal of management alignment.

Keywords

Cyanotech, CYAN, insider trading, Form 4, stock ownership, CEO, restricted stock units, RSU, common stock, beneficial ownership, equity compensation, Rule 10b5-1